Susan A. Knudson
2020 - Conatus Pharmaceuticals
In 2020, Susan A. Knudson earned a total compensation of $624.5K as Executive Vice President, Chief Financial Officer Corporate Secretary at Conatus Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $33,133 |
|---|---|
| Option Awards | $379,804 |
| Salary | $211,521 |
| Total | $624,458 |
Knudson received $379.8K in option awards, accounting for 61% of the total pay in 2020.
Knudson also received $33.1K in non-equity incentive plan and $211.5K in salary.
Rankings
In 2020, Susan A. Knudson's compensation ranked 10,369th out of 13,090 executives tracked by ExecPay. In other words, Knudson earned more than 20.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,369 out of 13,090 | 21st |
Division Manufacturing | 4,439 out of 5,624 | 21st |
Major group Chemicals And Allied Products | 1,836 out of 2,257 | 19th |
Industry group Drugs | 1,608 out of 1,957 | 18th |
Industry Pharmaceutical Preparations | 1,187 out of 1,462 | 19th |
Source: SEC filing on April 15, 2021.
Knudson's colleagues
We found three more compensation records of executives who worked with Susan A. Knudson at Conatus Pharmaceuticals in 2020.
News
Conatus Pharmaceuticals CFO Susan Knudson's 2022 pay jumps 26% to $681K
May 1, 2023
Conatus Pharmaceuticals CEO Steven Mento's 2020 pay slips 5% to $1.3M
April 15, 2021
Pfenex CEO Evert Schimmelpennink's 2019 pay rises 11% to $1.8M
April 1, 2020
Neothetics CEO Saundra Pelletier's 2018 pay jumps 401% to $8.3M
April 24, 2019
Pfenex CEO Evert Schimmelpennink's 2018 pay jumps 47% to $1.6M
April 4, 2019